nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—Tooth abscess—Metformin—metabolic syndrome X	0.00607	0.0698	CcSEcCtD
Sunitinib—Nail disorder—Metformin—metabolic syndrome X	0.00391	0.0449	CcSEcCtD
Sunitinib—Fungal infection—Metformin—metabolic syndrome X	0.00328	0.0377	CcSEcCtD
Sunitinib—Blood disorder—Metformin—metabolic syndrome X	0.00304	0.0349	CcSEcCtD
Sunitinib—Nasal congestion—Metformin—metabolic syndrome X	0.00202	0.0232	CcSEcCtD
Sunitinib—Renal impairment—Metformin—metabolic syndrome X	0.00193	0.0222	CcSEcCtD
Sunitinib—Hypoglycaemia—Metformin—metabolic syndrome X	0.00189	0.0217	CcSEcCtD
Sunitinib—Pain in extremity—Metformin—metabolic syndrome X	0.00184	0.0212	CcSEcCtD
Sunitinib—Dehydration—Metformin—metabolic syndrome X	0.00171	0.0197	CcSEcCtD
Sunitinib—Liver function test abnormal—Metformin—metabolic syndrome X	0.0017	0.0195	CcSEcCtD
Sunitinib—Abdominal pain upper—Metformin—metabolic syndrome X	0.00168	0.0193	CcSEcCtD
Sunitinib—Nasopharyngitis—Metformin—metabolic syndrome X	0.00165	0.0189	CcSEcCtD
Sunitinib—Abdominal distension—Metformin—metabolic syndrome X	0.0016	0.0184	CcSEcCtD
Sunitinib—SGK3—adipose tissue—metabolic syndrome X	0.00159	0.00428	CbGeAlD
Sunitinib—STK39—cardiovascular system—metabolic syndrome X	0.00159	0.00428	CbGeAlD
Sunitinib—PRPF4B—kidney—metabolic syndrome X	0.00158	0.00425	CbGeAlD
Sunitinib—ICK—adipose tissue—metabolic syndrome X	0.00158	0.00424	CbGeAlD
Sunitinib—KIT—endothelium—metabolic syndrome X	0.00157	0.00423	CbGeAlD
Sunitinib—CSNK2A1—cardiovascular system—metabolic syndrome X	0.00157	0.00422	CbGeAlD
Sunitinib—Pancreatitis—Metformin—metabolic syndrome X	0.00156	0.0179	CcSEcCtD
Sunitinib—STK39—kidney—metabolic syndrome X	0.00156	0.00419	CbGeAlD
Sunitinib—MYLK—cardiovascular system—metabolic syndrome X	0.00155	0.00417	CbGeAlD
Sunitinib—CSNK2A1—kidney—metabolic syndrome X	0.00154	0.00413	CbGeAlD
Sunitinib—Abdominal discomfort—Metformin—metabolic syndrome X	0.00152	0.0175	CcSEcCtD
Sunitinib—CHEK2—adipose tissue—metabolic syndrome X	0.00152	0.0041	CbGeAlD
Sunitinib—NUAK1—adipose tissue—metabolic syndrome X	0.00152	0.0041	CbGeAlD
Sunitinib—ERN1—liver—metabolic syndrome X	0.00152	0.00408	CbGeAlD
Sunitinib—MYLK—kidney—metabolic syndrome X	0.00152	0.00408	CbGeAlD
Sunitinib—INSR—adipose tissue—metabolic syndrome X	0.00151	0.00407	CbGeAlD
Sunitinib—OXSR1—adipose tissue—metabolic syndrome X	0.00151	0.00407	CbGeAlD
Sunitinib—SNRK—adipose tissue—metabolic syndrome X	0.00151	0.00407	CbGeAlD
Sunitinib—Neutropenia—Metformin—metabolic syndrome X	0.00149	0.0171	CcSEcCtD
Sunitinib—RPS6KA2—adipose tissue—metabolic syndrome X	0.00149	0.004	CbGeAlD
Sunitinib—STK38—adipose tissue—metabolic syndrome X	0.00149	0.004	CbGeAlD
Sunitinib—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00148	0.017	CcSEcCtD
Sunitinib—PKN1—adipose tissue—metabolic syndrome X	0.00146	0.00394	CbGeAlD
Sunitinib—CSNK1G2—adipose tissue—metabolic syndrome X	0.00146	0.00394	CbGeAlD
Sunitinib—STK17B—liver—metabolic syndrome X	0.00146	0.00393	CbGeAlD
Sunitinib—KIT—blood vessel—metabolic syndrome X	0.00145	0.0039	CbGeAlD
Sunitinib—PRPF4—adipose tissue—metabolic syndrome X	0.00144	0.00388	CbGeAlD
Sunitinib—HIPK2—cardiovascular system—metabolic syndrome X	0.00144	0.00387	CbGeAlD
Sunitinib—HIPK3—cardiovascular system—metabolic syndrome X	0.00144	0.00387	CbGeAlD
Sunitinib—PRPF4B—adipose tissue—metabolic syndrome X	0.00142	0.00383	CbGeAlD
Sunitinib—Infestation NOS—Metformin—metabolic syndrome X	0.00142	0.0163	CcSEcCtD
Sunitinib—Infestation—Metformin—metabolic syndrome X	0.00142	0.0163	CcSEcCtD
Sunitinib—PDGFRB—blood vessel—metabolic syndrome X	0.00142	0.00381	CbGeAlD
Sunitinib—HIPK2—kidney—metabolic syndrome X	0.00141	0.00378	CbGeAlD
Sunitinib—HIPK3—kidney—metabolic syndrome X	0.00141	0.00378	CbGeAlD
Sunitinib—STK39—adipose tissue—metabolic syndrome X	0.0014	0.00377	CbGeAlD
Sunitinib—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00139	0.016	CcSEcCtD
Sunitinib—CSNK2A1—adipose tissue—metabolic syndrome X	0.00138	0.00372	CbGeAlD
Sunitinib—DAPK3—cardiovascular system—metabolic syndrome X	0.00138	0.00372	CbGeAlD
Sunitinib—MYLK—adipose tissue—metabolic syndrome X	0.00137	0.00368	CbGeAlD
Sunitinib—STK17A—liver—metabolic syndrome X	0.00135	0.00362	CbGeAlD
Sunitinib—STK4—adipose tissue—metabolic syndrome X	0.00134	0.00361	CbGeAlD
Sunitinib—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00134	0.0154	CcSEcCtD
Sunitinib—ROCK1—cardiovascular system—metabolic syndrome X	0.00133	0.00357	CbGeAlD
Sunitinib—CDK14—liver—metabolic syndrome X	0.00133	0.00357	CbGeAlD
Sunitinib—PHKG2—adipose tissue—metabolic syndrome X	0.00132	0.00355	CbGeAlD
Sunitinib—STK24—adipose tissue—metabolic syndrome X	0.00131	0.00352	CbGeAlD
Sunitinib—LATS2—liver—metabolic syndrome X	0.00131	0.00352	CbGeAlD
Sunitinib—CDK16—liver—metabolic syndrome X	0.00131	0.00352	CbGeAlD
Sunitinib—ROCK1—kidney—metabolic syndrome X	0.0013	0.00349	CbGeAlD
Sunitinib—Bradycardia—Metformin—metabolic syndrome X	0.0013	0.0149	CcSEcCtD
Sunitinib—DAPK2—adipose tissue—metabolic syndrome X	0.0013	0.00349	CbGeAlD
Sunitinib—DYRK1A—cardiovascular system—metabolic syndrome X	0.00129	0.00348	CbGeAlD
Sunitinib—STK16—adipose tissue—metabolic syndrome X	0.00127	0.00343	CbGeAlD
Sunitinib—Hepatitis—Metformin—metabolic syndrome X	0.00127	0.0146	CcSEcCtD
Sunitinib—HIPK2—adipose tissue—metabolic syndrome X	0.00127	0.00341	CbGeAlD
Sunitinib—HIPK3—adipose tissue—metabolic syndrome X	0.00127	0.00341	CbGeAlD
Sunitinib—Hypoaesthesia—Metformin—metabolic syndrome X	0.00127	0.0146	CcSEcCtD
Sunitinib—DYRK1A—kidney—metabolic syndrome X	0.00127	0.0034	CbGeAlD
Sunitinib—RIOK2—adipose tissue—metabolic syndrome X	0.00125	0.00338	CbGeAlD
Sunitinib—Oedema peripheral—Metformin—metabolic syndrome X	0.00125	0.0144	CcSEcCtD
Sunitinib—Connective tissue disorder—Metformin—metabolic syndrome X	0.00125	0.0144	CcSEcCtD
Sunitinib—MAP4K1—adipose tissue—metabolic syndrome X	0.00124	0.00334	CbGeAlD
Sunitinib—CLK4—liver—metabolic syndrome X	0.00124	0.00334	CbGeAlD
Sunitinib—MAP4K4—cardiovascular system—metabolic syndrome X	0.00124	0.00334	CbGeAlD
Sunitinib—FLT3—cardiovascular system—metabolic syndrome X	0.00122	0.00329	CbGeAlD
Sunitinib—DAPK3—adipose tissue—metabolic syndrome X	0.00122	0.00328	CbGeAlD
Sunitinib—MAP4K4—kidney—metabolic syndrome X	0.00121	0.00326	CbGeAlD
Sunitinib—CLK2—adipose tissue—metabolic syndrome X	0.00121	0.00325	CbGeAlD
Sunitinib—RPS6KA3—cardiovascular system—metabolic syndrome X	0.00121	0.00324	CbGeAlD
Sunitinib—MAP4K2—adipose tissue—metabolic syndrome X	0.0012	0.00323	CbGeAlD
Sunitinib—DAPK1—liver—metabolic syndrome X	0.0012	0.00323	CbGeAlD
Sunitinib—MAP2K1—cardiovascular system—metabolic syndrome X	0.0012	0.00322	CbGeAlD
Sunitinib—Eye disorder—Metformin—metabolic syndrome X	0.00119	0.0137	CcSEcCtD
Sunitinib—STK3—adipose tissue—metabolic syndrome X	0.00119	0.00319	CbGeAlD
Sunitinib—CSNK1A1—cardiovascular system—metabolic syndrome X	0.00118	0.00318	CbGeAlD
Sunitinib—Cardiac disorder—Metformin—metabolic syndrome X	0.00118	0.0136	CcSEcCtD
Sunitinib—Flushing—Metformin—metabolic syndrome X	0.00118	0.0136	CcSEcCtD
Sunitinib—RPS6KA3—kidney—metabolic syndrome X	0.00118	0.00317	CbGeAlD
Sunitinib—CLK1—cardiovascular system—metabolic syndrome X	0.00117	0.00316	CbGeAlD
Sunitinib—MAP2K1—kidney—metabolic syndrome X	0.00117	0.00315	CbGeAlD
Sunitinib—STK11—liver—metabolic syndrome X	0.00116	0.00312	CbGeAlD
Sunitinib—BRD4—liver—metabolic syndrome X	0.00116	0.00312	CbGeAlD
Sunitinib—CSNK1A1—kidney—metabolic syndrome X	0.00116	0.00311	CbGeAlD
Sunitinib—Angiopathy—Metformin—metabolic syndrome X	0.00116	0.0133	CcSEcCtD
Sunitinib—CAMK2G—cardiovascular system—metabolic syndrome X	0.00115	0.0031	CbGeAlD
Sunitinib—Immune system disorder—Metformin—metabolic syndrome X	0.00115	0.0132	CcSEcCtD
Sunitinib—RIOK1—liver—metabolic syndrome X	0.00115	0.00309	CbGeAlD
Sunitinib—RPS6KA1—liver—metabolic syndrome X	0.00115	0.00309	CbGeAlD
Sunitinib—CLK1—kidney—metabolic syndrome X	0.00115	0.00309	CbGeAlD
Sunitinib—Mediastinal disorder—Metformin—metabolic syndrome X	0.00115	0.0132	CcSEcCtD
Sunitinib—Chills—Metformin—metabolic syndrome X	0.00114	0.0131	CcSEcCtD
Sunitinib—DYRK1A—adipose tissue—metabolic syndrome X	0.00114	0.00307	CbGeAlD
Sunitinib—TNIK—liver—metabolic syndrome X	0.00113	0.00303	CbGeAlD
Sunitinib—PRKAA1—cardiovascular system—metabolic syndrome X	0.00113	0.00303	CbGeAlD
Sunitinib—LRRK2—kidney—metabolic syndrome X	0.00112	0.00301	CbGeAlD
Sunitinib—SGK3—liver—metabolic syndrome X	0.00112	0.003	CbGeAlD
Sunitinib—MERTK—adipose tissue—metabolic syndrome X	0.00111	0.003	CbGeAlD
Sunitinib—PTK2B—cardiovascular system—metabolic syndrome X	0.00111	0.003	CbGeAlD
Sunitinib—FLT4—cardiovascular system—metabolic syndrome X	0.00111	0.00299	CbGeAlD
Sunitinib—Erythema—Metformin—metabolic syndrome X	0.00111	0.0127	CcSEcCtD
Sunitinib—Malnutrition—Metformin—metabolic syndrome X	0.00111	0.0127	CcSEcCtD
Sunitinib—ICK—liver—metabolic syndrome X	0.00111	0.00298	CbGeAlD
Sunitinib—PRKAA1—kidney—metabolic syndrome X	0.0011	0.00296	CbGeAlD
Sunitinib—MAP4K4—adipose tissue—metabolic syndrome X	0.00109	0.00294	CbGeAlD
Sunitinib—Flatulence—Metformin—metabolic syndrome X	0.00109	0.0126	CcSEcCtD
Sunitinib—PTK2B—kidney—metabolic syndrome X	0.00109	0.00293	CbGeAlD
Sunitinib—NUAK2—adipose tissue—metabolic syndrome X	0.00109	0.00292	CbGeAlD
Sunitinib—Dysgeusia—Metformin—metabolic syndrome X	0.00109	0.0125	CcSEcCtD
Sunitinib—MAP3K12—adipose tissue—metabolic syndrome X	0.00108	0.0029	CbGeAlD
Sunitinib—NUAK1—liver—metabolic syndrome X	0.00107	0.00287	CbGeAlD
Sunitinib—Muscle spasms—Metformin—metabolic syndrome X	0.00107	0.0122	CcSEcCtD
Sunitinib—RPS6KA3—adipose tissue—metabolic syndrome X	0.00106	0.00286	CbGeAlD
Sunitinib—OXSR1—liver—metabolic syndrome X	0.00106	0.00285	CbGeAlD
Sunitinib—INSR—liver—metabolic syndrome X	0.00106	0.00285	CbGeAlD
Sunitinib—SNRK—liver—metabolic syndrome X	0.00106	0.00285	CbGeAlD
Sunitinib—MAP2K1—adipose tissue—metabolic syndrome X	0.00106	0.00284	CbGeAlD
Sunitinib—MAP2K2—cardiovascular system—metabolic syndrome X	0.00105	0.00284	CbGeAlD
Sunitinib—RPS6KA2—liver—metabolic syndrome X	0.00104	0.00281	CbGeAlD
Sunitinib—STK38—liver—metabolic syndrome X	0.00104	0.00281	CbGeAlD
Sunitinib—CSNK1A1—adipose tissue—metabolic syndrome X	0.00104	0.0028	CbGeAlD
Sunitinib—CLK1—adipose tissue—metabolic syndrome X	0.00104	0.00279	CbGeAlD
Sunitinib—MAP2K2—kidney—metabolic syndrome X	0.00103	0.00278	CbGeAlD
Sunitinib—PKN1—liver—metabolic syndrome X	0.00103	0.00276	CbGeAlD
Sunitinib—CSNK1G2—liver—metabolic syndrome X	0.00103	0.00276	CbGeAlD
Sunitinib—TBK1—cardiovascular system—metabolic syndrome X	0.00103	0.00276	CbGeAlD
Sunitinib—TYK2—cardiovascular system—metabolic syndrome X	0.00102	0.00274	CbGeAlD
Sunitinib—CAMK2G—adipose tissue—metabolic syndrome X	0.00102	0.00273	CbGeAlD
Sunitinib—BMP2K—adipose tissue—metabolic syndrome X	0.00102	0.00273	CbGeAlD
Sunitinib—PRPF4—liver—metabolic syndrome X	0.00101	0.00272	CbGeAlD
Sunitinib—LRRK2—adipose tissue—metabolic syndrome X	0.00101	0.00271	CbGeAlD
Sunitinib—TBK1—kidney—metabolic syndrome X	0.001	0.0027	CbGeAlD
Sunitinib—PRPF4B—liver—metabolic syndrome X	0.000998	0.00268	CbGeAlD
Sunitinib—TYK2—kidney—metabolic syndrome X	0.000997	0.00268	CbGeAlD
Sunitinib—PRKAA1—adipose tissue—metabolic syndrome X	0.000993	0.00267	CbGeAlD
Sunitinib—RPS6KB1—cardiovascular system—metabolic syndrome X	0.000986	0.00265	CbGeAlD
Sunitinib—PTK2B—adipose tissue—metabolic syndrome X	0.000982	0.00264	CbGeAlD
Sunitinib—FGR—cardiovascular system—metabolic syndrome X	0.00098	0.00264	CbGeAlD
Sunitinib—FLT4—adipose tissue—metabolic syndrome X	0.000979	0.00263	CbGeAlD
Sunitinib—AXL—cardiovascular system—metabolic syndrome X	0.000977	0.00263	CbGeAlD
Sunitinib—CSNK2A1—liver—metabolic syndrome X	0.000971	0.00261	CbGeAlD
Sunitinib—FGFR1—adipose tissue—metabolic syndrome X	0.000966	0.0026	CbGeAlD
Sunitinib—CSNK1E—adipose tissue—metabolic syndrome X	0.000966	0.0026	CbGeAlD
Sunitinib—RPS6KB1—kidney—metabolic syndrome X	0.000965	0.0026	CbGeAlD
Sunitinib—RET—kidney—metabolic syndrome X	0.000959	0.00258	CbGeAlD
Sunitinib—MYLK—liver—metabolic syndrome X	0.000959	0.00258	CbGeAlD
Sunitinib—Hypertension—Metformin—metabolic syndrome X	0.000957	0.011	CcSEcCtD
Sunitinib—IRAK4—adipose tissue—metabolic syndrome X	0.000951	0.00256	CbGeAlD
Sunitinib—Chest pain—Metformin—metabolic syndrome X	0.000944	0.0108	CcSEcCtD
Sunitinib—Myalgia—Metformin—metabolic syndrome X	0.000944	0.0108	CcSEcCtD
Sunitinib—STK4—liver—metabolic syndrome X	0.000941	0.00253	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000937	0.0108	CcSEcCtD
Sunitinib—FGFR2—cardiovascular system—metabolic syndrome X	0.000932	0.00251	CbGeAlD
Sunitinib—ULK3—adipose tissue—metabolic syndrome X	0.00093	0.0025	CbGeAlD
Sunitinib—MAP2K2—adipose tissue—metabolic syndrome X	0.00093	0.0025	CbGeAlD
Sunitinib—JAK2—cardiovascular system—metabolic syndrome X	0.000927	0.00249	CbGeAlD
Sunitinib—PHKG2—liver—metabolic syndrome X	0.000924	0.00249	CbGeAlD
Sunitinib—MAP3K2—adipose tissue—metabolic syndrome X	0.000923	0.00248	CbGeAlD
Sunitinib—STK24—liver—metabolic syndrome X	0.000919	0.00247	CbGeAlD
Sunitinib—MAP3K7—adipose tissue—metabolic syndrome X	0.000915	0.00246	CbGeAlD
Sunitinib—FYN—cardiovascular system—metabolic syndrome X	0.000914	0.00246	CbGeAlD
Sunitinib—FGFR2—kidney—metabolic syndrome X	0.000911	0.00245	CbGeAlD
Sunitinib—JAK2—kidney—metabolic syndrome X	0.000907	0.00244	CbGeAlD
Sunitinib—Oedema—Metformin—metabolic syndrome X	0.000905	0.0104	CcSEcCtD
Sunitinib—TBK1—adipose tissue—metabolic syndrome X	0.000904	0.00243	CbGeAlD
Sunitinib—Infection—Metformin—metabolic syndrome X	0.000899	0.0103	CcSEcCtD
Sunitinib—TYK2—adipose tissue—metabolic syndrome X	0.000898	0.00242	CbGeAlD
Sunitinib—FYN—kidney—metabolic syndrome X	0.000894	0.00241	CbGeAlD
Sunitinib—STK16—liver—metabolic syndrome X	0.000894	0.0024	CbGeAlD
Sunitinib—MAP3K3—cardiovascular system—metabolic syndrome X	0.000893	0.0024	CbGeAlD
Sunitinib—Shock—Metformin—metabolic syndrome X	0.00089	0.0102	CcSEcCtD
Sunitinib—HIPK3—liver—metabolic syndrome X	0.000889	0.00239	CbGeAlD
Sunitinib—HIPK2—liver—metabolic syndrome X	0.000889	0.00239	CbGeAlD
Sunitinib—Nervous system disorder—Metformin—metabolic syndrome X	0.000887	0.0102	CcSEcCtD
Sunitinib—IRAK1—adipose tissue—metabolic syndrome X	0.000886	0.00238	CbGeAlD
Sunitinib—Thrombocytopenia—Metformin—metabolic syndrome X	0.000886	0.0102	CcSEcCtD
Sunitinib—TNK1—liver—metabolic syndrome X	0.00088	0.00237	CbGeAlD
Sunitinib—RIOK2—liver—metabolic syndrome X	0.00088	0.00237	CbGeAlD
Sunitinib—Skin disorder—Metformin—metabolic syndrome X	0.000879	0.0101	CcSEcCtD
Sunitinib—RPS6KB1—adipose tissue—metabolic syndrome X	0.00087	0.00234	CbGeAlD
Sunitinib—FGR—adipose tissue—metabolic syndrome X	0.000865	0.00233	CbGeAlD
Sunitinib—FLT1—cardiovascular system—metabolic syndrome X	0.000863	0.00232	CbGeAlD
Sunitinib—Anorexia—Metformin—metabolic syndrome X	0.000862	0.00991	CcSEcCtD
Sunitinib—AXL—adipose tissue—metabolic syndrome X	0.000861	0.00232	CbGeAlD
Sunitinib—DAPK3—liver—metabolic syndrome X	0.000854	0.0023	CbGeAlD
Sunitinib—CLK2—liver—metabolic syndrome X	0.000846	0.00228	CbGeAlD
Sunitinib—FLT1—kidney—metabolic syndrome X	0.000845	0.00227	CbGeAlD
Sunitinib—MAP4K2—liver—metabolic syndrome X	0.000843	0.00227	CbGeAlD
Sunitinib—STK3—liver—metabolic syndrome X	0.000831	0.00224	CbGeAlD
Sunitinib—SLK—adipose tissue—metabolic syndrome X	0.000829	0.00223	CbGeAlD
Sunitinib—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000824	0.00947	CcSEcCtD
Sunitinib—FGFR2—adipose tissue—metabolic syndrome X	0.000821	0.00221	CbGeAlD
Sunitinib—ROCK1—liver—metabolic syndrome X	0.00082	0.00221	CbGeAlD
Sunitinib—STK10—cardiovascular system—metabolic syndrome X	0.000817	0.0022	CbGeAlD
Sunitinib—JAK2—adipose tissue—metabolic syndrome X	0.000817	0.0022	CbGeAlD
Sunitinib—TAOK3—cardiovascular system—metabolic syndrome X	0.000814	0.00219	CbGeAlD
Sunitinib—Paraesthesia—Metformin—metabolic syndrome X	0.000812	0.00933	CcSEcCtD
Sunitinib—PDGFRA—cardiovascular system—metabolic syndrome X	0.000809	0.00218	CbGeAlD
Sunitinib—YES1—kidney—metabolic syndrome X	0.000807	0.00217	CbGeAlD
Sunitinib—Dyspnoea—Metformin—metabolic syndrome X	0.000806	0.00927	CcSEcCtD
Sunitinib—FYN—adipose tissue—metabolic syndrome X	0.000806	0.00217	CbGeAlD
Sunitinib—DYRK1A—liver—metabolic syndrome X	0.0008	0.00215	CbGeAlD
Sunitinib—STK10—kidney—metabolic syndrome X	0.0008	0.00215	CbGeAlD
Sunitinib—TAOK3—kidney—metabolic syndrome X	0.000797	0.00214	CbGeAlD
Sunitinib—Dyspepsia—Metformin—metabolic syndrome X	0.000796	0.00915	CcSEcCtD
Sunitinib—MAP3K3—adipose tissue—metabolic syndrome X	0.000788	0.00212	CbGeAlD
Sunitinib—MAP4K5—adipose tissue—metabolic syndrome X	0.000788	0.00212	CbGeAlD
Sunitinib—Decreased appetite—Metformin—metabolic syndrome X	0.000786	0.00904	CcSEcCtD
Sunitinib—MERTK—liver—metabolic syndrome X	0.000781	0.0021	CbGeAlD
Sunitinib—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000781	0.00898	CcSEcCtD
Sunitinib—Fatigue—Metformin—metabolic syndrome X	0.00078	0.00896	CcSEcCtD
Sunitinib—Constipation—Metformin—metabolic syndrome X	0.000774	0.00889	CcSEcCtD
Sunitinib—MAP4K4—liver—metabolic syndrome X	0.000767	0.00206	CbGeAlD
Sunitinib—NUAK2—liver—metabolic syndrome X	0.000762	0.00205	CbGeAlD
Sunitinib—FLT1—adipose tissue—metabolic syndrome X	0.000761	0.00205	CbGeAlD
Sunitinib—FLT3—liver—metabolic syndrome X	0.000756	0.00203	CbGeAlD
Sunitinib—MAP3K12—liver—metabolic syndrome X	0.000756	0.00203	CbGeAlD
Sunitinib—EPHB6—adipose tissue—metabolic syndrome X	0.000753	0.00202	CbGeAlD
Sunitinib—RPS6KA3—liver—metabolic syndrome X	0.000746	0.00201	CbGeAlD
Sunitinib—MAP2K1—liver—metabolic syndrome X	0.000741	0.00199	CbGeAlD
Sunitinib—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00074	0.0085	CcSEcCtD
Sunitinib—CSNK1A1—liver—metabolic syndrome X	0.000731	0.00197	CbGeAlD
Sunitinib—KDR—cardiovascular system—metabolic syndrome X	0.00073	0.00196	CbGeAlD
Sunitinib—MAP2K5—cardiovascular system—metabolic syndrome X	0.00073	0.00196	CbGeAlD
Sunitinib—YES1—adipose tissue—metabolic syndrome X	0.000727	0.00196	CbGeAlD
Sunitinib—CLK1—liver—metabolic syndrome X	0.000726	0.00195	CbGeAlD
Sunitinib—STK10—adipose tissue—metabolic syndrome X	0.000721	0.00194	CbGeAlD
Sunitinib—TAOK3—adipose tissue—metabolic syndrome X	0.000718	0.00193	CbGeAlD
Sunitinib—Abdominal pain—Metformin—metabolic syndrome X	0.000715	0.00822	CcSEcCtD
Sunitinib—KDR—kidney—metabolic syndrome X	0.000714	0.00192	CbGeAlD
Sunitinib—PDGFRA—adipose tissue—metabolic syndrome X	0.000714	0.00192	CbGeAlD
Sunitinib—CAMK2G—liver—metabolic syndrome X	0.000713	0.00192	CbGeAlD
Sunitinib—BMP2K—liver—metabolic syndrome X	0.000713	0.00192	CbGeAlD
Sunitinib—CSF1R—cardiovascular system—metabolic syndrome X	0.000712	0.00192	CbGeAlD
Sunitinib—LRRK2—liver—metabolic syndrome X	0.000707	0.0019	CbGeAlD
Sunitinib—PRKAA1—liver—metabolic syndrome X	0.000697	0.00187	CbGeAlD
Sunitinib—PTK2B—liver—metabolic syndrome X	0.000689	0.00185	CbGeAlD
Sunitinib—FLT4—liver—metabolic syndrome X	0.000687	0.00185	CbGeAlD
Sunitinib—CSNK1E—liver—metabolic syndrome X	0.000678	0.00182	CbGeAlD
Sunitinib—FGFR1—liver—metabolic syndrome X	0.000678	0.00182	CbGeAlD
Sunitinib—IRAK4—liver—metabolic syndrome X	0.000667	0.00179	CbGeAlD
Sunitinib—MAP2K2—liver—metabolic syndrome X	0.000652	0.00175	CbGeAlD
Sunitinib—ULK3—liver—metabolic syndrome X	0.000652	0.00175	CbGeAlD
Sunitinib—Asthenia—Metformin—metabolic syndrome X	0.000649	0.00746	CcSEcCtD
Sunitinib—MAP3K2—liver—metabolic syndrome X	0.000648	0.00174	CbGeAlD
Sunitinib—KIT—cardiovascular system—metabolic syndrome X	0.000647	0.00174	CbGeAlD
Sunitinib—KDR—adipose tissue—metabolic syndrome X	0.000644	0.00173	CbGeAlD
Sunitinib—MAP2K5—adipose tissue—metabolic syndrome X	0.000644	0.00173	CbGeAlD
Sunitinib—MAP3K7—liver—metabolic syndrome X	0.000641	0.00173	CbGeAlD
Sunitinib—Pruritus—Metformin—metabolic syndrome X	0.00064	0.00736	CcSEcCtD
Sunitinib—TBK1—liver—metabolic syndrome X	0.000634	0.00171	CbGeAlD
Sunitinib—KIT—kidney—metabolic syndrome X	0.000633	0.0017	CbGeAlD
Sunitinib—PDGFRB—cardiovascular system—metabolic syndrome X	0.000632	0.0017	CbGeAlD
Sunitinib—TYK2—liver—metabolic syndrome X	0.00063	0.00169	CbGeAlD
Sunitinib—CSF1R—adipose tissue—metabolic syndrome X	0.000628	0.00169	CbGeAlD
Sunitinib—IRAK1—liver—metabolic syndrome X	0.000622	0.00167	CbGeAlD
Sunitinib—Diarrhoea—Metformin—metabolic syndrome X	0.000619	0.00711	CcSEcCtD
Sunitinib—PDGFRB—kidney—metabolic syndrome X	0.000618	0.00166	CbGeAlD
Sunitinib—RPS6KB1—liver—metabolic syndrome X	0.00061	0.00164	CbGeAlD
Sunitinib—FGR—liver—metabolic syndrome X	0.000606	0.00163	CbGeAlD
Sunitinib—AXL—liver—metabolic syndrome X	0.000604	0.00162	CbGeAlD
Sunitinib—Dizziness—Metformin—metabolic syndrome X	0.000598	0.00687	CcSEcCtD
Sunitinib—SLK—liver—metabolic syndrome X	0.000581	0.00156	CbGeAlD
Sunitinib—CYP3A7—liver—metabolic syndrome X	0.000579	0.00156	CbGeAlD
Sunitinib—FGFR2—liver—metabolic syndrome X	0.000576	0.00155	CbGeAlD
Sunitinib—Vomiting—Metformin—metabolic syndrome X	0.000575	0.00661	CcSEcCtD
Sunitinib—JAK2—liver—metabolic syndrome X	0.000573	0.00154	CbGeAlD
Sunitinib—KIT—adipose tissue—metabolic syndrome X	0.00057	0.00153	CbGeAlD
Sunitinib—Rash—Metformin—metabolic syndrome X	0.00057	0.00655	CcSEcCtD
Sunitinib—Dermatitis—Metformin—metabolic syndrome X	0.00057	0.00655	CcSEcCtD
Sunitinib—Headache—Metformin—metabolic syndrome X	0.000567	0.00651	CcSEcCtD
Sunitinib—FYN—liver—metabolic syndrome X	0.000565	0.00152	CbGeAlD
Sunitinib—PDGFRB—adipose tissue—metabolic syndrome X	0.000557	0.0015	CbGeAlD
Sunitinib—MAP4K5—liver—metabolic syndrome X	0.000552	0.00149	CbGeAlD
Sunitinib—MAP3K3—liver—metabolic syndrome X	0.000552	0.00149	CbGeAlD
Sunitinib—Nausea—Metformin—metabolic syndrome X	0.000537	0.00617	CcSEcCtD
Sunitinib—FLT1—liver—metabolic syndrome X	0.000534	0.00144	CbGeAlD
Sunitinib—YES1—liver—metabolic syndrome X	0.00051	0.00137	CbGeAlD
Sunitinib—STK10—liver—metabolic syndrome X	0.000505	0.00136	CbGeAlD
Sunitinib—TAOK3—liver—metabolic syndrome X	0.000504	0.00135	CbGeAlD
Sunitinib—PDGFRA—liver—metabolic syndrome X	0.0005	0.00135	CbGeAlD
Sunitinib—CYP3A7-CYP3A51P—liver—metabolic syndrome X	0.000492	0.00132	CbGeAlD
Sunitinib—ABCC4—kidney—metabolic syndrome X	0.000492	0.00132	CbGeAlD
Sunitinib—ABCC2—kidney—metabolic syndrome X	0.000476	0.00128	CbGeAlD
Sunitinib—KDR—liver—metabolic syndrome X	0.000451	0.00121	CbGeAlD
Sunitinib—MAP2K5—liver—metabolic syndrome X	0.000451	0.00121	CbGeAlD
Sunitinib—ABCC4—adipose tissue—metabolic syndrome X	0.000444	0.00119	CbGeAlD
Sunitinib—CSF1R—liver—metabolic syndrome X	0.000441	0.00118	CbGeAlD
Sunitinib—KIT—liver—metabolic syndrome X	0.0004	0.00108	CbGeAlD
Sunitinib—KCNH2—cardiovascular system—metabolic syndrome X	0.000399	0.00107	CbGeAlD
Sunitinib—ABCB1—blood vessel—metabolic syndrome X	0.000393	0.00106	CbGeAlD
Sunitinib—PDGFRB—liver—metabolic syndrome X	0.000391	0.00105	CbGeAlD
Sunitinib—CYP3A5—kidney—metabolic syndrome X	0.000323	0.000867	CbGeAlD
Sunitinib—ABCG2—adipose tissue—metabolic syndrome X	0.000313	0.000842	CbGeAlD
Sunitinib—ABCC4—liver—metabolic syndrome X	0.000311	0.000837	CbGeAlD
Sunitinib—ABCC2—liver—metabolic syndrome X	0.000301	0.00081	CbGeAlD
Sunitinib—CYP3A5—adipose tissue—metabolic syndrome X	0.000291	0.000782	CbGeAlD
Sunitinib—CYP3A4—kidney—metabolic syndrome X	0.000242	0.000651	CbGeAlD
Sunitinib—ABCG2—liver—metabolic syndrome X	0.00022	0.000591	CbGeAlD
Sunitinib—CYP3A5—liver—metabolic syndrome X	0.000204	0.000548	CbGeAlD
Sunitinib—ABCB1—cardiovascular system—metabolic syndrome X	0.000175	0.000471	CbGeAlD
Sunitinib—ABCB1—kidney—metabolic syndrome X	0.000171	0.000461	CbGeAlD
Sunitinib—ABCB1—adipose tissue—metabolic syndrome X	0.000154	0.000415	CbGeAlD
Sunitinib—CYP3A4—liver—metabolic syndrome X	0.000153	0.000411	CbGeAlD
Sunitinib—ABCB1—liver—metabolic syndrome X	0.000108	0.000291	CbGeAlD
Sunitinib—MAP2K2—Signaling Pathways—INS—metabolic syndrome X	5.44e-06	1e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—SERPINE1—metabolic syndrome X	5.42e-06	1e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—SERPINE1—metabolic syndrome X	5.41e-06	1e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—AKT1—metabolic syndrome X	5.4e-06	9.98e-06	CbGpPWpGaD
Sunitinib—FGR—Immune System—AKT1—metabolic syndrome X	5.38e-06	9.94e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CCL2—metabolic syndrome X	5.35e-06	9.89e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IRS1—metabolic syndrome X	5.34e-06	9.87e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—HMGCR—metabolic syndrome X	5.33e-06	9.84e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GOT2—metabolic syndrome X	5.33e-06	9.84e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IRS1—metabolic syndrome X	5.31e-06	9.82e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—TGFB1—metabolic syndrome X	5.31e-06	9.82e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IL6—metabolic syndrome X	5.31e-06	9.81e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—INS—metabolic syndrome X	5.31e-06	9.8e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IL6—metabolic syndrome X	5.27e-06	9.74e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IGF1—metabolic syndrome X	5.26e-06	9.72e-06	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—AKT1—metabolic syndrome X	5.26e-06	9.71e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—TGFB1—metabolic syndrome X	5.25e-06	9.69e-06	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	5.22e-06	9.65e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCL2—metabolic syndrome X	5.22e-06	9.65e-06	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—AKT1—metabolic syndrome X	5.2e-06	9.62e-06	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—AKT1—metabolic syndrome X	5.2e-06	9.6e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—NOS3—metabolic syndrome X	5.18e-06	9.57e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOB—metabolic syndrome X	5.17e-06	9.55e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—NOS3—metabolic syndrome X	5.17e-06	9.54e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—TGFB1—metabolic syndrome X	5.15e-06	9.52e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TGFB1—metabolic syndrome X	5.15e-06	9.51e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IGF1—metabolic syndrome X	5.13e-06	9.48e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—INS—metabolic syndrome X	5.11e-06	9.45e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—INS—metabolic syndrome X	5.09e-06	9.4e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IRS1—metabolic syndrome X	5.08e-06	9.38e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCL2—metabolic syndrome X	5.03e-06	9.3e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PPARG—metabolic syndrome X	5.03e-06	9.29e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PLA2G4A—metabolic syndrome X	5.03e-06	9.29e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCL2—metabolic syndrome X	5.01e-06	9.25e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SERPINE1—metabolic syndrome X	4.99e-06	9.23e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PPARG—metabolic syndrome X	4.99e-06	9.21e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—G6PD—metabolic syndrome X	4.96e-06	9.17e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TGFB1—metabolic syndrome X	4.96e-06	9.16e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IGF1—metabolic syndrome X	4.95e-06	9.14e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—LPL—metabolic syndrome X	4.94e-06	9.12e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—INS—metabolic syndrome X	4.93e-06	9.12e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TGFB1—metabolic syndrome X	4.92e-06	9.1e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IGF1—metabolic syndrome X	4.92e-06	9.09e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—AKT1—metabolic syndrome X	4.9e-06	9.05e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—INS—metabolic syndrome X	4.89e-06	9.04e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—TGFB1—metabolic syndrome X	4.89e-06	9.04e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—TGFB1—metabolic syndrome X	4.88e-06	9.01e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SERPINE1—metabolic syndrome X	4.87e-06	9.01e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—INS—metabolic syndrome X	4.86e-06	8.98e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—AKT1—metabolic syndrome X	4.86e-06	8.98e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	4.84e-06	8.95e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCL2—metabolic syndrome X	4.78e-06	8.84e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TGFB1—metabolic syndrome X	4.78e-06	8.82e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TGFB1—metabolic syndrome X	4.78e-06	8.82e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NOS3—metabolic syndrome X	4.77e-06	8.81e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ABCA1—metabolic syndrome X	4.75e-06	8.77e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	4.75e-06	8.77e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL6—metabolic syndrome X	4.75e-06	8.77e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LPA—metabolic syndrome X	4.73e-06	8.75e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GCKR—metabolic syndrome X	4.73e-06	8.75e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL6—metabolic syndrome X	4.71e-06	8.7e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IGF1—metabolic syndrome X	4.7e-06	8.69e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SERPINE1—metabolic syndrome X	4.7e-06	8.68e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CD36—metabolic syndrome X	4.69e-06	8.67e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SERPINE1—metabolic syndrome X	4.67e-06	8.63e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NOS3—metabolic syndrome X	4.65e-06	8.6e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TGFB1—metabolic syndrome X	4.65e-06	8.6e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GGT1—metabolic syndrome X	4.6e-06	8.49e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GOT1—metabolic syndrome X	4.6e-06	8.49e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	4.58e-06	8.47e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL6—metabolic syndrome X	4.55e-06	8.41e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOA5—metabolic syndrome X	4.54e-06	8.39e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—ALB—metabolic syndrome X	4.52e-06	8.36e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—TGFB1—metabolic syndrome X	4.5e-06	8.32e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NOS3—metabolic syndrome X	4.49e-06	8.29e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—ALB—metabolic syndrome X	4.48e-06	8.28e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL6—metabolic syndrome X	4.47e-06	8.25e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SERPINE1—metabolic syndrome X	4.47e-06	8.25e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NOS3—metabolic syndrome X	4.46e-06	8.24e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—TGFB1—metabolic syndrome X	4.39e-06	8.12e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—AKT1—metabolic syndrome X	4.38e-06	8.09e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PPARA—metabolic syndrome X	4.36e-06	8.06e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—AKT1—metabolic syndrome X	4.34e-06	8.03e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL6—metabolic syndrome X	4.34e-06	8.01e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—NOS3—metabolic syndrome X	4.33e-06	7.99e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—NOS3—metabolic syndrome X	4.29e-06	7.92e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL6—metabolic syndrome X	4.28e-06	7.91e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL6—metabolic syndrome X	4.27e-06	7.89e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NOS3—metabolic syndrome X	4.26e-06	7.88e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—TGFB1—metabolic syndrome X	4.24e-06	7.83e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL6—metabolic syndrome X	4.23e-06	7.82e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AGT—metabolic syndrome X	4.22e-06	7.8e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	4.22e-06	7.8e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—TGFB1—metabolic syndrome X	4.21e-06	7.78e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL6—metabolic syndrome X	4.21e-06	7.77e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL6—metabolic syndrome X	4.21e-06	7.77e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—AKT1—metabolic syndrome X	4.2e-06	7.76e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOE—metabolic syndrome X	4.14e-06	7.65e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—AKT1—metabolic syndrome X	4.12e-06	7.61e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOA1—metabolic syndrome X	4.09e-06	7.56e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TGFB1—metabolic syndrome X	4.04e-06	7.47e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—TGFB1—metabolic syndrome X	4.03e-06	7.44e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—metabolic syndrome X	4.02e-06	7.43e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—metabolic syndrome X	4e-06	7.4e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AKT1—metabolic syndrome X	4e-06	7.39e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—metabolic syndrome X	3.99e-06	7.37e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—metabolic syndrome X	3.98e-06	7.36e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—metabolic syndrome X	3.96e-06	7.31e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—metabolic syndrome X	3.95e-06	7.3e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AKT1—metabolic syndrome X	3.95e-06	7.3e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AKT1—metabolic syndrome X	3.94e-06	7.28e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—metabolic syndrome X	3.92e-06	7.25e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AKT1—metabolic syndrome X	3.9e-06	7.21e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOB—metabolic syndrome X	3.9e-06	7.21e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—metabolic syndrome X	3.88e-06	7.17e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—AKT1—metabolic syndrome X	3.88e-06	7.17e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AKT1—metabolic syndrome X	3.88e-06	7.17e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—metabolic syndrome X	3.88e-06	7.16e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TGFB1—metabolic syndrome X	3.83e-06	7.08e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	3.79e-06	7.01e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	3.78e-06	6.99e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—metabolic syndrome X	3.76e-06	6.95e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LIPC—metabolic syndrome X	3.76e-06	6.95e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GCK—metabolic syndrome X	3.76e-06	6.95e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOC3—metabolic syndrome X	3.74e-06	6.91e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—metabolic syndrome X	3.73e-06	6.9e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—LPL—metabolic syndrome X	3.72e-06	6.88e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TGFB1—metabolic syndrome X	3.72e-06	6.87e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—metabolic syndrome X	3.71e-06	6.86e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AKT1—metabolic syndrome X	3.71e-06	6.86e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—AKT1—metabolic syndrome X	3.69e-06	6.82e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—metabolic syndrome X	3.68e-06	6.81e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—metabolic syndrome X	3.68e-06	6.8e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—metabolic syndrome X	3.68e-06	6.79e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—metabolic syndrome X	3.68e-06	6.79e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TGFB1—metabolic syndrome X	3.67e-06	6.79e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—metabolic syndrome X	3.67e-06	6.79e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—metabolic syndrome X	3.65e-06	6.75e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—metabolic syndrome X	3.65e-06	6.74e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CETP—metabolic syndrome X	3.63e-06	6.7e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TGFB1—metabolic syndrome X	3.61e-06	6.67e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TGFB1—metabolic syndrome X	3.61e-06	6.67e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PPARG—metabolic syndrome X	3.6e-06	6.66e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—metabolic syndrome X	3.6e-06	6.65e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—metabolic syndrome X	3.6e-06	6.65e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—metabolic syndrome X	3.6e-06	6.65e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—metabolic syndrome X	3.59e-06	6.63e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—metabolic syndrome X	3.58e-06	6.62e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—metabolic syndrome X	3.58e-06	6.61e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CD36—metabolic syndrome X	3.54e-06	6.54e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—INS—metabolic syndrome X	3.53e-06	6.53e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—metabolic syndrome X	3.51e-06	6.48e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	3.47e-06	6.42e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—metabolic syndrome X	3.47e-06	6.41e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—metabolic syndrome X	3.46e-06	6.39e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—metabolic syndrome X	3.45e-06	6.37e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—metabolic syndrome X	3.44e-06	6.35e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TGFB1—metabolic syndrome X	3.42e-06	6.33e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—metabolic syndrome X	3.42e-06	6.33e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TGFB1—metabolic syndrome X	3.42e-06	6.31e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—metabolic syndrome X	3.4e-06	6.28e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—metabolic syndrome X	3.39e-06	6.27e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—metabolic syndrome X	3.39e-06	6.27e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—metabolic syndrome X	3.39e-06	6.26e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	3.37e-06	6.23e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—metabolic syndrome X	3.32e-06	6.13e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—metabolic syndrome X	3.32e-06	6.13e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—metabolic syndrome X	3.32e-06	6.13e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—metabolic syndrome X	3.31e-06	6.12e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—metabolic syndrome X	3.31e-06	6.11e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARA—metabolic syndrome X	3.29e-06	6.08e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—metabolic syndrome X	3.29e-06	6.07e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	3.28e-06	6.06e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GOT2—metabolic syndrome X	3.28e-06	6.06e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—metabolic syndrome X	3.24e-06	5.99e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—metabolic syndrome X	3.23e-06	5.98e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—metabolic syndrome X	3.19e-06	5.9e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—metabolic syndrome X	3.19e-06	5.89e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AGT—metabolic syndrome X	3.19e-06	5.89e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—metabolic syndrome X	3.17e-06	5.87e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—metabolic syndrome X	3.17e-06	5.86e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TGFB1—metabolic syndrome X	3.15e-06	5.83e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—metabolic syndrome X	3.13e-06	5.78e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOE—metabolic syndrome X	3.12e-06	5.77e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NOS3—metabolic syndrome X	3.1e-06	5.73e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOA1—metabolic syndrome X	3.09e-06	5.7e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TGFB1—metabolic syndrome X	3.08e-06	5.69e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—metabolic syndrome X	3.05e-06	5.64e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—metabolic syndrome X	3.04e-06	5.63e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—metabolic syndrome X	3.03e-06	5.61e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—metabolic syndrome X	3.03e-06	5.6e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TGFB1—metabolic syndrome X	2.97e-06	5.48e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TGFB1—metabolic syndrome X	2.95e-06	5.45e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—metabolic syndrome X	2.94e-06	5.44e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—metabolic syndrome X	2.93e-06	5.41e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	2.92e-06	5.4e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	2.92e-06	5.4e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—metabolic syndrome X	2.89e-06	5.34e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	2.84e-06	5.24e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GGT1—metabolic syndrome X	2.83e-06	5.23e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GOT1—metabolic syndrome X	2.83e-06	5.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TGFB1—metabolic syndrome X	2.82e-06	5.21e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—metabolic syndrome X	2.81e-06	5.19e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—metabolic syndrome X	2.8e-06	5.18e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—metabolic syndrome X	2.8e-06	5.17e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—metabolic syndrome X	2.77e-06	5.12e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARG—metabolic syndrome X	2.72e-06	5.03e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—metabolic syndrome X	2.72e-06	5.02e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—metabolic syndrome X	2.72e-06	5.02e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—INS—metabolic syndrome X	2.67e-06	4.93e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—metabolic syndrome X	2.66e-06	4.92e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—metabolic syndrome X	2.59e-06	4.78e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—metabolic syndrome X	2.58e-06	4.77e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—metabolic syndrome X	2.57e-06	4.76e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—metabolic syndrome X	2.55e-06	4.72e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—metabolic syndrome X	2.51e-06	4.63e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—metabolic syndrome X	2.51e-06	4.63e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—metabolic syndrome X	2.45e-06	4.52e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOB—metabolic syndrome X	2.4e-06	4.44e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—metabolic syndrome X	2.38e-06	4.4e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—metabolic syndrome X	2.38e-06	4.39e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—metabolic syndrome X	2.37e-06	4.39e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NOS3—metabolic syndrome X	2.34e-06	4.32e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	2.34e-06	4.32e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—metabolic syndrome X	2.32e-06	4.28e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LPL—metabolic syndrome X	2.29e-06	4.24e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—metabolic syndrome X	2.23e-06	4.13e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—metabolic syndrome X	2.22e-06	4.11e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—metabolic syndrome X	2.19e-06	4.05e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CD36—metabolic syndrome X	2.18e-06	4.03e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—metabolic syndrome X	2.14e-06	3.95e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—metabolic syndrome X	2.14e-06	3.95e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—metabolic syndrome X	2.12e-06	3.93e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—metabolic syndrome X	2.06e-06	3.81e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—metabolic syndrome X	2.05e-06	3.79e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARA—metabolic syndrome X	2.03e-06	3.75e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—metabolic syndrome X	1.99e-06	3.67e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—metabolic syndrome X	1.97e-06	3.64e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AGT—metabolic syndrome X	1.96e-06	3.63e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—metabolic syndrome X	1.96e-06	3.62e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOE—metabolic syndrome X	1.92e-06	3.55e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOA1—metabolic syndrome X	1.9e-06	3.51e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARG—metabolic syndrome X	1.68e-06	3.1e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—INS—metabolic syndrome X	1.64e-06	3.04e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—metabolic syndrome X	1.51e-06	2.78e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NOS3—metabolic syndrome X	1.44e-06	2.66e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—metabolic syndrome X	1.42e-06	2.63e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	1.32e-06	2.44e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.08e-06	1.99e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—metabolic syndrome X	6.62e-07	1.22e-06	CbGpPWpGaD
